Expression of herpes simplex virus‐thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells

• Published in: International journal of cancer 2001-03, Vol.91 (5), p.723-727
• Main Authors: Miyauchi, Motohiro, Yoshida, Yu, Tada, Yuji, Narita, Mitsuro, Maeda, Tomoko, Bahar, Rumana, Kadomatsu, Kenji, Muramatsu, Takashi, Matsubara, Shuichiro, Nakagawara, Akira, Sakiyama, Shigeru, Tagawa, Masatoshi
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Blotting, Northern; Carrier Proteins - genetics; Chloramphenicol O-Acetyltransferase; Cytokines; Dose-Response Relationship, Drug; Female; Ganciclovir - pharmacology; gene therapy; Genetic Therapy; HSV‐TK; Humans; Medical sciences; Mice; Mice, Nude; Midkine; Models, Genetic; Other treatments; Promoter Regions, Genetic; Simplexvirus - enzymology; Thymidine Kinase - biosynthesis; Thymidine Kinase - genetics; Time Factors; Transcriptional Activation; Transfection; Treatment. General aspects; Tumor Cells, Cultured; tumor promoter; Tumors
• ISSN: 0020-7136; 1097-0215
• DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1112>3.0.CO;2-X

A selective expression of suicide gene(s) in tumor cells should produce a preferential cytotoxic effect on tumors. Promoter region(s) of a gene that is expressed in tumors but not in normal tissues can be useful for tumor‐specific transcription of a suicide gene. Midkine (MK), a growth/differentiation factor, is expressed predominantly in various types of human tumors, whereas its expression in adult normal tissues is highly restricted. In our study, we showed that a 2.3‐kb fragment of genomic DNA in the 5′ upstream region of the MK gene could activate transcription of a fused reporter gene in MK‐positive cells but not in MK‐negative cells. Efficiency of the cis‐acting sequence to permit expression of an exogenous gene in tumor cells was comparable with that of the SV40 promoter. Regulated expression of the herpes simplex virus‐thymidine kinase (HSV‐TK) gene under the control of the MK promoter conferred increased sensitivity to ganciclovir (GCV) on MK‐positive tumor cells. Administration of GCV into nude mice that were implanted with MK‐positive tumor cells that expressed the HSV‐TK gene under the control of the MK promoter could suppress the subsequent tumor growth. Expression of therapeutic genes restricted to tumors can be achieved by the use of the putative cis‐acting MK promoter. © 2001 Wiley‐Liss, Inc.